BPDCN MYB Fusions Regulate Cell Cycle Genes, Impair Differentiation and Induce Myeloid-Dendritic Cell Leukemia [HoxCutRun]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 27 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 27 samples: 21 distinct titles, 6 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- BPDCN MYB fusions regulate cell cycle genes, impair differentiation, and induce myeloid-dendritic cell leukemiaJCI insight · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE261666_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1088234 and SRA study SRP495354. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 27 sample titles: 21 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8148235 Hoxb8 leukemia, Cdkn2a-KO MYB-PLEKHO1, H3K27ac
- GSM8148236 Hoxb8 leukemia, Cdkn2a-KO MYB-PLEKHO1, IgG
- GSM8148237 Hoxb8 leukemia, Cdkn2a-KO MYB-PLEKHO1, V5
- GSM8148238 Hoxb8 MS5, Cdkn2a-KO MYB-PLEKHO1, H3K27ac
- GSM8148239 Hoxb8 MS5, Cdkn2a-KO MYB-PLEKHO1, IgG
- GSM8148240 Hoxb8 MS5, Cdkn2a-KO MYB-PLEKHO1, V5 Rep1
- GSM8148241 Hoxb8 MS5, Cdkn2a-KO MYB-PLEKHO1, V5 Rep2
- GSM8148242 Hoxb8 MS5, Cdkn2a-KO MYB-TR, H3K27ac
- GSM8148243 Hoxb8 MS5, Cdkn2a-KO MYB-TR, IgG
- GSM8148244 Hoxb8 MS5, Cdkn2a-KO MYB-TR, V5 Rep1
- GSM8148245 Hoxb8 MS5, Cdkn2a-KO MYB-TR, V5 Rep2
- GSM8148246 Hoxb8 MS5, Cdkn2a-KO MYB-WT, H3K27ac
- GSM8148247 Hoxb8 MS5, Cdkn2a-KO MYB-WT, V5 IgG
- GSM8148248 Hoxb8 MS5, Cdkn2a-KO MYB-WT, V5 Rep1
- GSM8148249 Hoxb8 MS5, Cdkn2a-KO MYB-WT, V5 Rep2
- GSM8148250 Hoxb8 MS5, Cdkn2a-WT MYB-PLEKHO1, H3K27ac
- GSM8148251 Hoxb8 MS5, Cdkn2a-WT MYB-PLEKHO1, IgG
- GSM8148252 Hoxb8 MS5, Cdkn2a-WT MYB-PLEKHO1, V5 Rep1
- GSM8148253 Hoxb8 MS5, Cdkn2a-WT MYB-PLEKHO1, V5 Rep2
- GSM8148254 Hoxb8 MS5, Cdkn2a-WT MYB-TR, H3K27ac
- GSM8148255 Hoxb8 MS5, Cdkn2a-WT MYB-TR, IgG
- GSM8148256 Hoxb8 MS5, Cdkn2a-WT MYB-TR, V5 Rep1
- GSM8148257 Hoxb8 MS5, Cdkn2a-WT MYB-TR, V5 Rep2
- GSM8148258 Hoxb8 MS5, Cdkn2a-WT MYB-WT, H3K27ac
- GSM8148259 Hoxb8 MS5, Cdkn2a-WT MYB-WT, IgG
- GSM8148260 Hoxb8 MS5, Cdkn2a-WT MYB-WT, V5 Rep1
- GSM8148261 Hoxb8 MS5, Cdkn2a-WT MYB-WT, V5 Rep2
- GSE261767 BPDCN MYB Fusions Regulate Cell Cycle Genes, Impair Differentiation and Induce Myeloid-Dendritic Cell Leukemia [HoxRNASeq] 46 samples shares bpdcn, myb, myeloid-dendritic, regulate, leukemia, fusions, impair
- GSE240060 Myb is regulated by -81 enhancer eRNA transcript Myrlin through recruitment of MLL1 complex 8 samples shares myb, regulate
- GSE292744 BRD4 and MYB Inhibition Overcomes Venetoclax Resistance in EVI1-rearranged Acute Myeloid Leukemia 8 samples shares myb, leukemia
- GSE296152 Sustained MYB activity drives emergent enhancer activation and precise enhancer-promoter interactions [ATAC-seq] 9 samples shares myb
- GSE271328 MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer [ChIP-seq] 3 samples shares myb
- GSE271327 MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer [ATAC-seq] 3 samples shares myb
- GSE66970 C-Myb+ erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages 38 samples shares myb
- GSE279737 Compound mutations in HRC and MYBPC3 synergistically increase cardiac pathogenicity 12 samples shares myb
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.